{"id":"NCT00853073","sponsor":"Wills Eye","briefTitle":"Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?","officialTitle":"Does a New Add on (or Adjunctive) Therapy Used in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2009-02","primaryCompletion":"2012-01","completion":"2012-01","firstPosted":"2009-02-27","resultsPosted":"2015-03-12","lastUpdate":"2018-07-09"},"enrollment":63,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Glaucoma"],"interventions":[{"type":"DRUG","name":"bevacizumab","otherNames":["Avastin"]},{"type":"OTHER","name":"balanced salt solution","otherNames":[]}],"arms":[{"label":"Bevacizumab","type":"ACTIVE_COMPARATOR"},{"label":"balanced salt solution","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to see if a new add on (or adjunctive) therapy used in glaucoma surgery improves the success of needle bleb revisions.","primaryOutcome":{"measure":"Intraocular Pressure (IOP)","timeFrame":"6 months","effectByArm":[{"arm":"Treatment A (Bevacizumab)","deltaMin":11.52,"sd":null},{"arm":"Treatment B (Balanced Salt Solution)","deltaMin":12.83,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":5},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["25826644"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":29},"commonTop":["Shallow Anterior Chamber","Retinal/Choroidal folds","Endothelial folds","Hyphema","Choroidals"]}}